New Eye Drops , May Help People , With Age-Related Vision Problems. 'The New York Times' reports that a new prescription eye-drop that improves close-range vision could help many people with age-related vision problems. . Allergen's Vuity treats age-related vision loss, a condition called presbyopia. . According to 'The New York Times,' about 90% of adults over 45 in the U.S. suffer from presbyopia. . Dr. George O. Waring IV, the medical director of the Waring Vision Institute, led Allergan's clinical trials for Vuity. The results of the drug's Phase 3 clinical trials have not been published in a peer-reviewed journal. . In October, the drug was approved by the U.S. Food and Drug Administration. Dr. Waring said that most health and vision insurance won't cover Vuity. . A 30-day supply costs about $80. . Dr. Scott M. MacRae, an ophthalmologist at the University of Rochester’s Center for Visual Science, said that Vuity will work best for people with mild to moderate presbyopia. . 'The New York Times' notes that Vuity does not work for nearsightedness, farsightedness or astigmatism. . Pilocarpine, the active ingredient of Vuity, has reportedly been used to treat glaucoma for decades
